Key facts
- This page summarizes Marvin Slosman's Form 4 filing for BioCardia, Inc. (BCDA).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 07 Jul 2026, 22:03.
Marvin Slosman - 06 Jul 2026 Form 4 Insider Report for BioCardia, Inc. (BCDA)
- Reporting relationship
- Director
- Issuer ticker
- BCDA
- Reported as of
- 06 Jul 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 07 Jul 2026, 22:03:52 UTC
- Prior SEC filing
- 13 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ David McClung, by power of attorney
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Marvin Slosman filed Form 4 for BioCardia, Inc. (BCDA) on 07 Jul 2026.
Change
- Previous filing in this sequence was filed on 13 May 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001796908
Primary reporting owner
Slosman Marvin
- Relationship
- Director
- Address
- C/O BIOCARDIA, INC., 320 SOQUEL WAY, SUNNYVALE
- Signature
- /s/ David McClung, by power of attorney
- Signature date
- 07 Jul 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BCDA
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- Shares
- +8,000
- Change %
- +67%
- Price
- $0.000000*
- Shares after
- 20,000
- Date
- 06 Jul 2026
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
- 8,000
- Exercise price
- $1.20
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
One hundred percent of the shares are subject to the option vesting and becoming exercisable on the one-year anniversary of the date of grant, subject to the Reporting Person continuing as a service provider through such date.